Open letter: Selection of a new Executive Director of the European Chemicals Agency (ECHA) provides an opportunity for the EU to lead in the field of chemicals management and implementation of innovative science

Troy Seidle; Helena Kandarova; Thomas Hartung; Marcel Leist; Winfried Neuhaus; Horst Spielmann; Costanza Rovida

doi:10.14573/altex.2110271

pdf

Published: Jan 12, 2022

DOI: https://doi.org/10.14573/altex.2110271

Troy Seidle , Helena Kandarova, Thomas Hartung, Marcel Leist, Winfried Neuhaus, Horst Spielmann, Costanza Rovida
[show affiliations]

Troy Seidle

Humane Society International/Europe, Brussels, Belgium

Helena Kandarova

European Society of Toxicology In Vitro (ESTIV), Houten, The Netherlands; Slovak National Platform for 3Rs, Bratislava, Slovakia; Centre of Experimental Medicine SAS, Slovak Academy of Sciences, Bratislava, Slovakia

Thomas Hartung

Center for Alternatives to Animal Testing (CAAT), Johns Hopkins University, Bloomberg School of Public Health, Environmental Health and Engineering, Doerenkamp-Zbinden Chair for Evidence-based Toxicology, Baltimore, MD, USA; CAAT-Europe, University of Konstanz, Konstanz, Germany

https://orcid.org/0000-0003-1359-7689

Marcel Leist

Center for Alternatives to Animal Testing (CAAT) Europe, University of Konstanz, Konstanz, Germany; In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany

http://orcid.org/0000-0002-3778-8693

Winfried Neuhaus

European Society for Alternatives to Animal Testing (EUSAAT), Luftenberg/Donau, Austria

Horst Spielmann

European Society for Alternatives to Animal Testing (EUSAAT), Luftenberg/Donau, Austria

Costanza Rovida

ecopa, Vosselaar, Belgium

[hide affiliations]

How to Cite

Seidle, T., Kandarova, H., Hartung, T., Leist, M., Neuhaus, W., Spielmann, H. and Rovida, C. (2022) “Open letter: Selection of a new Executive Director of the European Chemicals Agency (ECHA) provides an opportunity for the EU to lead in the field of chemicals management and implementation of innovative science”, ALTEX - Alternatives to animal experimentation, 39(1), pp. 149–150. doi: 10.14573/altex.2110271.

Issue

Vol. 39 No. 1 (2022)

Section

Letter

This work is licensed under a Creative Commons Attribution 4.0 International License.

Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).

Most read articles by the same author(s)

Horst Spielmann, Editorial , ALTEX - Alternatives to animal experimentation: Vol. 13 No. Supp. 1 (1996): Egg yolk antibodies, IgY technology
Thomas Hartung, Stefan Fennrich, Matthias Fischer, Thomas Montag-Lessing, Albrecht Wendel, [Development and evaluation of a pyrogen test based on human whole blood ] [Article in German] , ALTEX - Alternatives to animal experimentation: Vol. 15 No. Supp. 1 (1998): 2. Paul-Ehrlich-Seminar über Tierschutzaspekte bei der Zulassung und Prüfung von immunologischen Arzneimitteln
Matthias Fischer, Katja Hartzsch, Thomas Hartung, Thomas Montag-Lessing, [First results in the prevaluation of the human whole blood assay for pyrogens in biological pharmaceuticals] [Article in German] , ALTEX - Alternatives to animal experimentation: Vol. 15 No. Supp. 1 (1998): 2. Paul-Ehrlich-Seminar über Tierschutzaspekte bei der Zulassung und Prüfung von immunologischen Arzneimitteln
Thomas Hartung, Reto Crameri, Albrecht Wendel, [Development of a pyrogen test based on rabbit blood] [Article in German] , ALTEX - Alternatives to animal experimentation: Vol. 15 No. Supp. 1 (1998): 2. Paul-Ehrlich-Seminar über Tierschutzaspekte bei der Zulassung und Prüfung von immunologischen Arzneimitteln
Thomas Hartung, Three Rs potential in the development and quality control of pharmaceuticals , ALTEX - Alternatives to animal experimentation: Vol. 18 No. Supp. 1 (2001): 25th Anniversary of FFVFF
Horst Spielmann, Editorial , ALTEX - Alternatives to animal experimentation: Vol. 19 No. Supp. 1 (2002): Linz 2001
Horst Spielmann, [White Paper of the European Commission - strategy for a new chemicals policy] [Article in German] , ALTEX - Alternatives to animal experimentation: Vol. 19 No. Supp. 1 (2002): Linz 2001
Andrea Seiler, Anke Visan, Ingeborg Pohl, Elke Genschow, Roland Buesen, Horst Spielmann, [Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development using murine embryonic stem cells (D3 cells)] [Article in German] , ALTEX - Alternatives to animal experimentation: Vol. 19 No. Supp. 1 (2002): Linz 2001
Costanza Rovida, Sylvia E. Escher, Matthias Herzler, Susanne H. Bennekou, Hennicke Kamp, Dinant E. Kroese, Lidka Maslankiewicz, Martijn J. Moné, Grace Patlewicz, Nisha Sipes, Leon van Aerts, Andrew White, Takashi Yamada, Bob van de Water, NAM-supported read-across: From case studies to regulatory guidance in safety assessment , ALTEX - Alternatives to animal experimentation: Vol. 38 No. 1 (2021)
Winfried Neuhaus, Consensus statement from the European Network of 3R Centres (EU3Rnet) , ALTEX - Alternatives to animal experimentation: Vol. 38 No. 1 (2021)

<< < 18 19 20 21 22 23 24 25 26 27 > >>

Article Sidebar

Main Article Content

Article Details

Most read articles by the same author(s)